A multicenter retrospective study to evaluate the efficacy and safety of platinum-based chemotherapy in combination with immunotherapy for extensive-stage small cell lung cancer in the real-world setting
Not Applicable
- Conditions
- extensive-stage small cell lung cancer
- Registration Number
- JPRN-UMIN000053134
- Lead Sponsor
- Shinshu University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 350
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who are judged by the attending doctor as inappropriate to participate in this clinical research
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Overall survival (Patients with platinum-based chemotherapy in combination with immunotherapy and Patients with platinum-based chemotherap)
- Secondary Outcome Measures
Name Time Method Progression free survival Objective response rate 1 year-OS, 2 year-OS Safety(severe toxicity)